BG
SNY icon

Bahl & Gaynor’s Sanofi SNY Stock Holding History

Bahl & Gaynor’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,129
Closed -$340K – 402
2016
Q2 		$340K Hold
8,129
– – ﹤0.01% 348
2016
Q1 		$326K Buy
8,129
+200
+3% +$8.04K ﹤0.01% 347
2015
Q4 		$338K Hold
7,929
– – ﹤0.01% 355
2015
Q3 		$376K Hold
7,929
– – 0.01% 349
2015
Q2 		$393K Hold
7,929
– – 0.01% 354
2015
Q1 		$392K Buy
7,929
+610
+8% +$29.2K 0.01% 334
2014
Q4 		$334K Sell
7,319
-7,541
-51% -$366K ﹤0.01% 354
2014
Q3 		$839K Hold
14,860
– – 0.01% 231
2014
Q2 		$790K Sell
14,860
-456
-3% -$24.2K 0.01% 229
2014
Q1 		$801K Buy
15,316
+86
+0.6% +$4.35K 0.01% 223
2013
Q4 		$817K Sell
15,230
-338
-2% -$17.4K 0.01% 214
2013
Q3 		$788K Buy
15,568
+338
+2% +$17.2K 0.01% 208
2013
Q2 		$784K Buy
+15,230
New +$812K 0.01% 205

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Bahl & Gaynor's SNY Position: Q3 2016 in Review

Bahl & Gaynor sold out of Sanofi (SNY) in Q3 2016, closing a stake of 8,129 shares — an estimated $340K sold.

Bahl & Gaynor first reported a position in SNY in Q2 2013 and held it in 13 quarters. The position peaked at $839K in Q3 2014. 450 funds tracked by Wall St. Rank hold SNY as of Q3 2016.

  • Bahl & Gaynor reported no remaining Sanofi position as of Q3 2016 after selling out during the quarter.
  • Bahl & Gaynor sold 8,129 Sanofi shares in Q3 2016, an estimated $340K.
  • Bahl & Gaynor first reported a position in Sanofi in Q2 2013 and held it in 13 quarters.
  • Bahl & Gaynor's Sanofi position peaked at $839K in Q3 2014.
  • 450 funds tracked by Wall St. Rank held Sanofi as of Q3 2016.

Based on Bahl & Gaynor's 13F filing for Q3 2016, filed 7 Nov 2016.